Literature DB >> 17352176

[A case of primary mediastinal choriocarcinoma in which FDG-PET was performed for the evaluation of the treatment].

Takehito Shukuya1, Satoshi Hirano, Yuichiro Takeda, Hideyuki Ito, Kaneyuki Hurihata, Haruhito Sugiyama, Nobuyuki Kobayashi, Koichiro Kudo.   

Abstract

A 61-year-old man visited another hospital with chief complaints of dry cough, appetite loss and body weight loss. On chest X ray film and CT, right supraclavicular and mediastinal lymph nodes were swollen. For further examination, he was referred to our hospital and diagnosed as primary mediastinal choriocarcinoma. We conducted surgery after four cycles of chemotherapy using cisplatin, etoposide and bleomycin. After chemotherapy, residual tumors were found on chest CT. In FDG-PET some parts of the residual tumors seen on CT showed much less uptake and the others showed similar uptake. Histologically the areas showing similar uptake contained more viable cells, and the other areas showing less uptake almost completely consisted of necrotic tissue. We believe FDG-PET can be useful to evaluate the viability of tumors after chemotherapy in extra gonadal choriocarcinoma in the mediastinum.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17352176

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  3 in total

1.  Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia.

Authors:  P Mapelli; G Mangili; M Picchio; C Gentile; E Rabaiotti; V Giorgione; E G Spinapolice; L Gianolli; C Messa; M Candiani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-12       Impact factor: 9.236

2.  Primary choriocarcinoma in mediastinum with multiple lung metastases in a male patient: A case report and a review of the literature.

Authors:  Song Zhang; Hui Gao; Xin-An Wang; Bin Liang; Dao-Wei Li; Yang Shao; Shu-Juan Jiang
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

3.  Primary choriocarcinoma of the posterior mediastinum in a male: A case report and review of the literature.

Authors:  Fangbiao Zhang; Weidong Zhang; Hongcan Shi; Gang Ye; Weiping Shi; Yusheng Shu; Guangyu Li
Journal:  Oncol Lett       Date:  2014-06-04       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.